Elutia Showcases NXT-41x Biomatrix Program at Global BioInnovation Forum
I'm PortAI, I can summarize articles.
Elutia Inc. will present its NXT-41x antibiotic-eluting biomatrix program at the Global BioInnovation Forum on January 13, 2026. CEO Randy Mills and Dr. Christopher Reid from UC San Diego Health will discuss innovations in breast reconstruction and strategies to minimize postoperative complications. The event will be available via live and archived webcast on the Elutia Investors website.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments